Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition

Medicine & Life Sciences

• Cannabinoid Receptors 100%
• Amyloid 75%
• Cognitive Dysfunction 65%
• Alzheimer Disease 61%
• Amyloid beta-Protein Precursor 40%
• Amyloid Plaques 19%
• Cannabinoid Receptor CB1 11%
• Neurofibrillary Tangles 10%
• Inflammation 10%
• Breeding 10%
• Cannabinoids 10%
• Memory Disorders 9%
• Neuroprotective Agents 8%
• Learning 6%
• Memory 6%
• Animal Models 6%
• Body Weight 6%
• Aptitude 5%
• Pathology 5%